StockData
Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX) shareholders

HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$0.28−0.00 (-0.74%)

Close on Nov 17, 2026Market cap $53.58MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
70.4%
134M of 190M shares
Institutional holders
162
21 new, 22 sold out
Net institutional buying
-23M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Rubric Capital Management LP
Joint filing with David Rosen (15.90%)
30,046,82815.90%13D (active) amendmentOct 15, 2025
David Rosen
Joint filing with Rubric Capital Management LP (17.50%)
29,100,72817.50%13D (active) amendmentAug 8, 2025
Clearline Capital LP
Joint filing with Clearline Capital LLC (6.70%), Marc Majzner (6.70%)
12,235,2396.70%13G (passive) amendmentDec 31, 2025
BlackRock, Inc.8,534,5675.60%13G (passive)Sep 30, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of HRTXValueChange% of portfolio
Rubric Capital Management LP30,046,82815.83%$12.82M–0.12%
Clearline Capital LP11,383,9616.00%$4.86M−851,2780.29%
BlackRock, Inc.10,550,7505.56%$4.50M+444,3280.00%
Velan Capital Investment Management LP8,753,2904.61%$3.74M–2.28%
Vanguard Capital Management LLC7,782,7414.10%$3.32M−27,5880.00%
Tejara Capital Ltd6,510,7953.43%$2.78M+174,0401.14%
Tang Capital Management LLC6,250,0003.29%$2.67M–0.12%
Geode Capital Management, LLC4,270,9802.25%$1.82M+260,8930.00%
Millennium Management LLC4,070,1012.14%$1.74M−3,560,4260.00%
JW Asset Management, LLC3,751,0731.98%$1.60M–0.50%
State Street Corp3,228,5571.70%$1.38M−615,1150.00%
UBS Group AG2,997,0731.58%$1.28M+711,1900.00%
Pale Fire Capital SE2,511,4781.32%$1.07M−204,8500.08%
Marshall Wace, Llp2,354,1931.24%$1.01MNew0.00%
Congress Park Capital LLC2,016,4471.06%$860.62K−2,016,2900.23%
Richmond Brothers, Inc.1,792,3190.94%$764.96K+355,6140.40%
Vanguard Portfolio Management LLC1,580,5100.83%$674.88K+271,1980.00%
Aqr Capital Management LLC1,553,8570.82%$663.19K+912,2700.00%
Renaissance Technologies LLC1,506,9000.79%$643.15K−211,4000.00%
Vanguard Fiduciary Trust Co1,365,1190.72%$582.91K+212,4050.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026162134M70.4%21 / 5840 / 2212M35M
Q1 2026167157M82.6%31 / 5244 / 2929M19M
Q4 2025170157M82.4%25 / 5743 / 2524M21M
Q3 2025172154M81.1%19 / 5752 / 1636M13M
Q2 2025171131M69.3%24 / 6532 / 1716M9M
Q1 2025165125M65.7%25 / 5146 / 1816M6M
Q4 2024161115M60.6%26 / 4251 / 358M15M
Q3 2024173122M64.3%22 / 6639 / 3821M20M
Q2 2024190130M68.3%45 / 6739 / 1519M9M
Q1 2024161120M63.1%28 / 4646 / 1814M7M
Q4 2023151113M59.5%30 / 4539 / 1821M26M
Q3 2023141118M62.4%14 / 3842 / 1925M6M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

100 funds held HRTX in Q2 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of HRTXValue% of fundAs of
Vanguard Total Stock Market Index Fund5,474,9472.88%$2.34M0.00%Jun 30, 2026
iShares Russell 2000 ETF3,684,5971.94%$1.57M0.00%Jun 30, 2026
Vanguard Extended Market Index Fund2,063,3611.09%$880.64K0.00%Jun 30, 2026
Fidelity Small Cap Index Fund1,626,1690.86%$806.91K0.00%Jul 31, 2026
iShares Russell 2000 Growth ETF1,361,3300.72%$581.02K0.00%Jun 30, 2026
Schwab U.S. Small-Cap ETF869,9040.46%$756.90K0.00%May 31, 2026
Vanguard Russell 2000 Index Fund783,9920.41%$682.15K0.00%May 31, 2026
Fidelity Extended Market Index Fund666,1600.35%$579.63K0.00%May 31, 2026
iShares Micro-Cap ETF537,3350.28%$229.33K0.02%Jun 30, 2026
iShares Russell 2000 Value ETF510,4280.27%$217.85K0.00%Jun 30, 2026
Vanguard Health Care Index Fund415,5080.22%$361.53K0.00%May 31, 2026
Schwab Small-Cap Index Fund413,5950.22%$205.23K0.00%Jul 31, 2026
Jacob Small Cap Growth Fund357,0970.19%$310.71K3.75%May 31, 2026
Fidelity Total Market Index Fund318,6410.17%$277.25K0.00%May 31, 2026
Fidelity Series Total Market Index Fund273,1880.14%$237.70K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Craig A. CollardChief Executive Officer, Director931,0860.49%Nov 3, 2026
Mark Earl HensleyChief Operating Officer201,6830.11%Nov 10, 2026
William P. ForbesEVP, Chief Development Officer260,7340.14%Nov 3, 2026
Ira DuarteEVP, Chief Financial Officer302,7240.16%Nov 3, 2026
Thomas CusackDirector53,9600.03%Feb 3, 2026
Michael KasetaDirector53,9600.03%Feb 3, 2026
Craig A. JohnsonDirector53,9600.03%Feb 3, 2026
Sharmila DissanaikeDirector53,9600.03%Feb 3, 2026
Adam MorganDirector8,877,0274.68%Feb 3, 2026
Waage ChristianDirector53,9600.03%Feb 3, 2026
Susan RodriguezDirector87,1800.05%Feb 4, 2025
Capital Management LP Rubric10% owner26,713,50314.07%Oct 17, 2025
David Efraim Rosen10% owner30,046,82815.83%Oct 17, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mark Earl Hensley
Chief Operating Officer
Nov 6, 2026Tax withholding−8,889$0.29$2.58K201,683
Mark Earl Hensley
Chief Operating Officer
Nov 6, 2026Option exercise+31,250––210,572
Craig A. Collard
Chief Executive Officer, Director
Oct 31, 2026Tax withholding−8,471$0.28$2.37K931,086
Craig A. Collard
Chief Executive Officer, Director
Oct 31, 2026Option exercise+34,788––939,557
Ira Duarte
EVP, Chief Financial Officer
Oct 31, 2026Tax withholding−3,327$0.28$932302,724
Ira Duarte
EVP, Chief Financial Officer
Oct 31, 2026Option exercise+11,695––306,051
William P. Forbes
EVP, Chief Development Officer
Oct 31, 2026Tax withholding−3,327$0.28$932260,734
William P. Forbes
EVP, Chief Development Officer
Oct 31, 2026Option exercise+11,695––264,061
Craig A. Collard
Chief Executive Officer, Director
Oct 30, 2026Tax withholding−12,181$0.28$3.41K904,769
Craig A. Collard
Chief Executive Officer, Director
Oct 30, 2026Option exercise+50,021––916,950
Ira Duarte
EVP, Chief Financial Officer
Oct 30, 2026Tax withholding−3,850$0.28$1.08K294,356
Ira Duarte
EVP, Chief Financial Officer
Oct 30, 2026Option exercise+13,535––298,206
William P. Forbes
EVP, Chief Development Officer
Oct 30, 2026Tax withholding−3,349$0.28$938252,366
William P. Forbes
EVP, Chief Development Officer
Oct 30, 2026Option exercise+11,770––255,715
Mark Earl Hensley
Chief Operating Officer
Oct 30, 2026Tax withholding−3,349$0.28$938179,322
Mark Earl Hensley
Chief Operating Officer
Oct 30, 2026Option exercise+11,770––182,671
Ira Duarte
EVP, Chief Financial Officer
Oct 19, 2026Tax withholding−1,102$0.36$397284,671
Ira Duarte
EVP, Chief Financial Officer
Oct 19, 2026Option exercise+3,874––285,773
William P. Forbes
EVP, Chief Development Officer
Oct 19, 2026Tax withholding−1,102$0.36$397243,945
William P. Forbes
EVP, Chief Development Officer
Oct 19, 2026Option exercise+3,874––245,047
Craig A. Collard
Chief Executive Officer, Director
Oct 19, 2026Tax withholding−3,360$0.36$1.21K866,929
Craig A. Collard
Chief Executive Officer, Director
Oct 19, 2026Option exercise+13,797––870,289
Mark Earl Hensley
Chief Operating Officer
Aug 6, 2026Tax withholding−8,888$0.50$4.44K170,901
Mark Earl Hensley
Chief Operating Officer
Aug 6, 2026Option exercise+31,250––179,789
Craig A. Collard
Chief Executive Officer, Director
Jul 31, 2026Option exercise+34,789––856,492
Ira Duarte
EVP, Chief Financial Officer
Jul 31, 2026Tax withholding−3,326$0.50$1.66K281,899
Ira Duarte
EVP, Chief Financial Officer
Jul 31, 2026Option exercise+11,694––285,225
Mark Earl Hensley
Chief Operating Officer
Jul 31, 2026Option exercise+11,769––148,539
William P. Forbes
EVP, Chief Development Officer
Jul 31, 2026Tax withholding−3,326$0.50$1.66K241,173
William P. Forbes
EVP, Chief Development Officer
Jul 31, 2026Option exercise+11,694––244,499
Craig A. Collard
Chief Executive Officer, Director
Jul 30, 2026Option exercise+50,021––821,703
Ira Duarte
EVP, Chief Financial Officer
Jul 30, 2026Option exercise+13,535––277,381
Ira Duarte
EVP, Chief Financial Officer
Jul 30, 2026Tax withholding−3,850$0.50$1.93K273,531
William P. Forbes
EVP, Chief Development Officer
Jul 30, 2026Option exercise+11,769––236,153
William P. Forbes
EVP, Chief Development Officer
Jul 30, 2026Tax withholding−3,348$0.50$1.67K232,805
Ira Duarte
EVP, Chief Financial Officer
Jul 19, 2026Tax withholding−1,101$0.47$517263,846
Ira Duarte
EVP, Chief Financial Officer
Jul 19, 2026Option exercise+3,874––264,947
Craig A. Collard
Chief Executive Officer, Director
Jul 19, 2026Option exercise+13,797––771,682
William P. Forbes
EVP, Chief Development Officer
Jul 19, 2026Option exercise+3,874––225,485
William P. Forbes
EVP, Chief Development Officer
Jul 19, 2026Tax withholding−1,101$0.47$517224,384
Ira Duarte
EVP, Chief Financial Officer
Jun 16, 2026Option exercise+12,500––264,628
Ira Duarte
EVP, Chief Financial Officer
Jun 16, 2026Tax withholding−3,555$0.38$1.35K261,073
William P. Forbes
EVP, Chief Development Officer
Jun 6, 2026Option exercise+12,500––221,611
Mark Earl Hensley
Chief Operating Officer
May 6, 2026Option exercise+125,000––136,770
Craig A. Collard
Chief Executive Officer, Director
Apr 30, 2026Option exercise+50,021––757,885
Craig A. Collard
Chief Executive Officer, Director
Apr 30, 2026Option exercise+34,789––696,841
William P. Forbes
EVP, Chief Development Officer
Apr 30, 2026Option exercise+11,694––197,341
William P. Forbes
EVP, Chief Development Officer
Apr 30, 2026Option exercise+11,770––209,111
Ira Duarte
EVP, Chief Financial Officer
Apr 30, 2026Option exercise+13,535––252,128
Ira Duarte
EVP, Chief Financial Officer
Apr 30, 2026Option exercise+11,694––227,570
Mark Earl Hensley
Chief Operating Officer
Apr 30, 2026Option exercise+11,770––11,770
William P. Forbes
EVP, Chief Development Officer
Apr 19, 2026Option exercise+3,874––185,647
Ira Duarte
EVP, Chief Financial Officer
Apr 19, 2026Option exercise+3,874––215,876
Craig A. Collard
Chief Executive Officer, Director
Apr 19, 2026Option exercise+13,797––662,052
Craig A. Collard
Chief Executive Officer, Director
Apr 3, 2026Option exercise+62,500––648,255
Ira Duarte
EVP, Chief Financial Officer
Jan 31, 2026Option exercise+11,695––195,356
William P. Forbes
EVP, Chief Development Officer
Jan 31, 2026Option exercise+11,695––181,773
Craig A. Collard
Chief Executive Officer, Director
Jan 31, 2026Option exercise+34,789––571,710
Michael Kaseta
Director
Jan 30, 2026Award+53,960––53,960
Sharmila Dissanaike
Director
Jan 30, 2026Award+53,960––53,960

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
22.84%
34M shares short
Days to cover
19.5
At 2M shares a day
Change since last report
-7.4%
From 37M shares
Short volume, 20 days
40.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Heron Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 210,633 shares on Sep 30, 2026 over the last 90 days.

Congress trades

1 trade in Heron Therapeutics reported by 1 member of the House

MemberTypeTradedAmountFiled
Ashley Hinson Arenholz
IA01 · spouse
SoldMar 31, 2021$1K–15KApr 5, 2021

See a number that looks wrong?